Male sex and hispanic ethnicity are associated with increased risk of early-onset colorectal cancer
1. Male sex and Hispanic ethnicity were associated with increased risk of early-onset colorectal cancer (EOCRC). 2. Among females, higher ...
Tag: colorectal cancer
2 Minute Medicine Rewind June 29, 2026
Diet Quality and Dementia Risk in Older Adults With Alzheimer Pathology 1. Greater adherence to a dietary pattern with lower ...
2 Minute Medicine Rewind May 25, 2026
Validation of 2 Syncope Risk Scores and Comparison With Physician Risk Estimation 1. The Canadian Syncope Risk Score (CSRS) and ...
![2MM: AI Roundup- AI Cancer Test, Smarter Hospitals, Faster Drug Discovery, and Mental Health Tech [May 2nd, 2025]](https://www.2minutemedicine.com/wp-content/uploads/2025/05/Untitled-design-350x250.png)
Artificial intelligence predicts colorectal cancer in ulcerative colitis with 99% accuracy
1. A new AI workflow utilizing large language models can predict with 99% accuracy which ulcerative colitis patients will remain ...
2MM: AI Roundup- Medtronic’s AI-Robotic Spine Platform, 90% Phase I Success for AI-Designed Drugs, and UCSD’s AI Cancer Risk Predictor [Feb 17th, 2026]
Medtronic Stealth AXiS system integrates AI-robotics for spine care The FDA recently issued a landmark clearance for a surgical platform ...
#VisualAbstract: Encorafenib, Cetuximab, and mFOLFOX6 Improves Survival in BRAF-Mutated Colorectal Cancer
Click here to read this study in NEJM. ©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Sotorasib plus panitumumab may be a promising treatment option for colorectal cancer
1. While not statistically significant, the use of sotorasib plus panitumumab may have a 30% relative risk reduction in the ...
#VisualAbstract: Invitation to Fecal Immunochemical Test is Noninferior to Colonoscopy Screening in Colorectal Cancer Mortality
Click here to read this study in the Lancet. ©2025 2 Minute Medicine, Inc. All rights reserved. No works may be ...
Nivolumab plus ipilimumab improves progression-free survival in metastatic colorectal cancer
1. Progression-free survival was significantly greater in the nivolumab plus ipilimumab group compared to nivolumab alone. 2. Treatment-related adverse events ...
Fluorouracil, leucovorin and irinotecan plus panitumumab for the treatment of metastatic colorectal cancer
1. An intermittent strategy with fluorouracil, leucovorin and irinotecan (FOLFIRI) plus panitumumab (PAN) following induction was feasible, showed reduced toxicity ...
